More specifically, IGF-1 LR3 is an 83 amino acid analog of IGF-1 comprising the complete human IGF-1 sequence with the substitution of an Arg (R) for the Glu(E) at position three, and a 13 amino acid extension peptide at the N terminus from methionyl porcine Growth Hormone [1]
It is a well-known risk factor for many serious chronic conditions [2, 4]
Asmar A, Simonsen L, Asmar M, Madsbad S, Holst JJ, Frandsen E, Moro C, Jonassen T, Bulow J
Active targeting systems still require further optimization in terms of reproducibility, characterization and large-scale production to approach clinical translation, and alternative strategies such as endogenous targeting by modifying lipid composition to modulate protein corona may be more reliable in a near future
Tesamorelin drives body composition changes through metabolic and hormonal shifts